Keesler Medical Center - Keesler AFB
Keesler Air Force Base, Mississippi 39534-2576
0 studies enrolling now · 84 studies all time
What they study most
Bladder Cancer, Brain Tumor, Brain Tumors, Brain and Central Nervous System Tumors, Breast Cancer, Cardiac Toxicity, Central Nervous System Tumor, Central Nervous System Tumors, Cervical Cancer, Childhood Germ Cell Tumor, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ
Studies at this site
- Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma — Completed
- Combination Chemotherapy in Treating Women With Breast Cancer — Completed
- Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer — Completed
- Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed — Completed
- Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma — Completed
- Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
- S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma — Completed
- Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer — Completed
- Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer — Completed
- Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer — Completed
- Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa — Stopped early
- S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer — Completed
- S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia — Completed
- SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia — Completed
- S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia — Completed
- S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome — Completed
- S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma — Stopped early
- S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
- S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission — Completed
- Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma — Completed
- Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia — Completed
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma — Completed
- Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma — Completed
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia — Completed
- Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma — Completed
- Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors — Completed
- Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas — Completed
- S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer — Stopped early
- Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia — Completed
- Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer — Stopped early
- Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors — Completed
- Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia — Completed
- Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
- BMS-247550 in Treating Patients With Advanced Pancreatic Cancer — Completed
- Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer — Completed
- Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma — Completed
- Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer — Completed
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer — Completed
- Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
- Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer — Completed
- Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer — Completed
- Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy — Completed
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma — Completed
- Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer — Completed
- Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum — Completed
- Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer — Completed
- Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer — Stopped early
- Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer — Stopped early
- Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer — Completed